Ayurveda Cough Syrup

A Single Arm prospective clinical Study to evaluate efficacy of Gojihvadi Cough syrup in the management of Cough (Kasa)

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2020/08/027382

Enrollment

Registered

2020-08-26

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J399- Disease of upper respiratory tract, unspecified

Interventions

Intervention1: Gojihvadi cough syrup: Gojihvadi cough syrup will be given in the dose of 10ml thrice a day for duration of 7 days to the subject. Control Intervention1: not applicable: not applicable

Eligibility

Inclusion criteria

Inclusion criteria: Patients age group of 18 years to 60 years. Patients of either gender will be included.

Exclusion criteria

Exclusion criteria: • Patients below age group of 18 years and above 60 years. • Patients with chronic debilitating disease or disorders.

Design outcomes

Primary

Measure	Time frame
Decrease frequency of cough. Decrease intensity of cough. Decrease duration between two cough attacks.Timepoint: 7 days	—

Secondary

Measure	Time frame
Decrease frequency of cough. Decrease intensity of cough. Decrease duration between two cough attacks.Timepoint: 14 days	—

Countries

India

Contacts

Public ContactDr Raghuveer

Parul Institute of Ayurveda Parul University

drabolipatil@gmail.com9422783313

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026